Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunomedics (IMMU) - moderated -- Ignore unavailable to you. Want to Upgrade?

To: sysiphus who wrote (63065)	4/10/2025 12:57:33 PM
From: galt	4 Recommendations Recommended By dorightbythem jhcimmu luckydog88 sukit Read Replies (1) \| Respond to of 63287

I continue to believe that IBRX, much like IMMU, will soon move much higher. Now that their financing is complete there is very little downside, IMO, and lots of upside. Of course, most everyone has favorites to pump. Although I'm not a fan of their founder and CEO, the science, much like IMMU, is a proven winner in one indication and looks to add more. Best.